EVIFX
Price
$12.70
Change
-$0.01 (-0.08%)
Updated
Sep 5 closing price
Net Assets
1.07B
RLBEX
Price
$37.93
Change
+$0.20 (+0.53%)
Updated
Sep 5 closing price
Net Assets
257.73B
Interact to see
Advertisement

EVIFX vs RLBEX

Header iconEVIFX vs RLBEX Comparison
Open Charts EVIFX vs RLBEXBanner chart's image
Eaton Vance Balanced A
Price$12.70
Change-$0.01 (-0.08%)
VolumeN/A
Net Assets1.07B
American Funds American Balanced R4
Price$37.93
Change+$0.20 (+0.53%)
VolumeN/A
Net Assets257.73B
EVIFX vs RLBEX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EVIFX vs. RLBEX commentary
Sep 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EVIFX is a Buy and RLBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 258B vs. EVIFX (1.07B). RLBEX pays higher dividends than EVIFX: RLBEX (1.79) vs EVIFX (1.20). EVIFX was incepted earlier than RLBEX: EVIFX (93 years) vs RLBEX (23 years). EVIFX (0.97) is less costly to investors than RLBEX (0.59). RLBEX is a more actively managed with annual turnover of: 44.00 vs. EVIFX (5.00). RLBEX has a lower initial minimum investment than EVIFX: RLBEX (250) vs EVIFX (1000). RLBEX annual gain was more profitable for investors over the last year : 9.36 vs. EVIFX (7.60). RLBEX return over 5 years is better than : 38.95 vs. EVIFX (28.98).
EVIFXRLBEXEVIFX / RLBEX
Total Expense Ratio0.970.59164%
Annual Report Gross Expense Ratio0.970.59164%
Fund Existence93 years23 years-
Gain YTD8.43910.76478%
Front Load5%N/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets1.07B258B0%
Annual Yield % from dividends1.201.7967%
Returns for 1 year7.609.3681%
Returns for 3 years35.1439.1190%
Returns for 5 years28.9838.9574%
Returns for 10 years69.6276.5191%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
LOAR76.482.75
+3.73%
Loar Holdings
DRTS3.600.11
+3.15%
Alpha Tau Medical Ltd
VTVT18.31-0.23
-1.24%
vTv Therapeutics
BGM7.25-0.16
-2.16%
BGM Group Ltd
JPM294.38-9.44
-3.11%
JPMorgan Chase & Co